Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • New Drugs
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: We have made updates to the logos on our site. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources

Resources

  • Diabetes (431)
  • Endocrinology (9)
  • Hyperglycemia (24)
  • Hypoglycemia (22)
  • Other (15)
  • Prediabetes (2)
  • Resources (129)
    • Charts (41)
    • Guidelines (38)
    • Letters (2)
    • Natural Medicines / Supplements (3)
    • Patient Education (11)
    • PL Voices (61)
    • Quality Measures (17)
  • Thyroid Disorders (41)
91 - 105 of 129 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Patient Education: Avandia and Risk of Heart Attack August 2010
Other: Senate Concerns about Avandia April 2010
Commentary: Avandia and Cardiovascular Safety: Ongoing Review April 2010
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Other: Pancreatitis and Byetta (Exenatide) November 2009
Guideline: Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes (ADA, 2009) September 2009
Commentary: New Drug: Onglyza (Saxagliptin) September 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Commentary: How Much Insulin Is Too Much? January 2009
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 September 2008
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved